Latest headlines

Loading...

Propecia Generic For Male Pattern Baldness

The drug propecia generic was originally intended for treating prostate enlargement or benign prostatic hyperplasia. When its branded name Proscar was released in the market, it was noticed that men who were suffering from androgenic alopecia were also being treated by the drug.  It was then that the manufacturer took notice and created some clinical studies and found out that Proscar, which came at 5mg, which at lowered dosage, particularly 1mg, could help fight androgenic alopecia.  Several years later, the brand Propecia, an offshoot of the drug Proscar was approved by the Food and Drug Administration as a treatment for androgenic alopecia.

Who is propecia generic intended for?

Propecia generic is meant for men suffering from male pattern baldness and want to stop the progression of their hair loss.  Signs of male pattern baldness would be the thinning of hair on the front, the receding of hairline on the temples, and the formation of a bald spot on the crown.  In due time, this type of baldness will let you end up bald from top to front with a rim of hair at the sides and back.  propecia generic is effective against this type of hair loss because it is able to treat it at the root of the cause – the formation of the hormone dihydrotestosterone (DHT).  Basically, this hair loss treatment prevents your hair loss from getting any worse.  If your hair loss is due to androgenic alopecia, then this is the medication for you.  Consult your doctor to know what type of hair loss you are having. Read more…

Canada approves H1N1 flu vaccine

Arepanrix, GlaxoSmithKline's vaccine against the pandemic H1N1 flu, was today given Health Canada's stamp of approval. "This is a milestone in our efforts to fight the pandemic H1N1 flu virus," Health Minister Leona Aglukkaq said in a statement. "Thanks to careful planning we now have a safe and effective vaccine being distributed to provinces and territories that they will be rolling out in a matter of days."

The Public Health Agency of Canada's vaccination recommendations are as follows:

  • All Canadians 10 years of age and older should receive one dose of adjuvanted vaccine;
  • Children from six months and up to 10 years of age should receive the adjuvanted vaccine in two half-doses, administered at least 21 days apart;
  • Children age 0-6 months – immunization not authorized; and
  • Pregnant women should receive one dose of the unadjuvanted vaccine, of which Canada has ordered 1.8 million doses. In cases where the unadjuvanted vaccine is unavailable and pandemic H1N1 flu rates are high or increasing in the community, women more than 20 weeks pregnant should be offered one dose of the adjuvanted vaccine.
The unadjuvanted version of the vaccine is supposed to be available within a couple of weeks.

Get Canadian Medicine news by email or in an RSS reader

3 comments:

  1. chris22 October, 2009 1:03 AM

    If you are looking for tour&travels related information, you can scan the resource page of herbsncures.com and get travel related links on the resource section of the website.

    Delete
  2. ben23 October, 2009 3:41 PM

    MediaCurves.com conducted a study among 300 Americans viewing a clip of the assistant surgeon general addressing concerns about the H1N1 and seasonal flu vaccines. Results found that parents with children under the age of 18 are more likely to have them vaccinated against the H1N1 virus after viewing a message from the assistant surgeon general. The majority of respondents (70%) reported that they are confident that the H1N1 vaccine is successful in preventing the H1N1 flu.
    More in depth results can be seen at:
    http://www.mediacurves.com/HealthCare/J7604-H1N1Vaccine/Index.cfm
    Thanks,
    Ben

    Delete
  3. Cristine12 November, 2009 2:34 AM

    You have great post that really interests to many readers. I really appreciate your work. interesting and informative!

    Delete